دورية أكاديمية
Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells.
العنوان: | Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. |
---|---|
المؤلفون: | Stowell SR; Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD |
المصدر: | Blood [Blood] 2007 Jan 01; Vol. 109 (1), pp. 219-27. Date of Electronic Publication: 2006 Aug 29. |
نوع المنشور: | Comparative Study; Journal Article; Research Support, N.I.H., Extramural |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-4971 (Print) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2021- : [New York] : Elsevier Original Publication: New York, Grune & Stratton [etc.] |
مواضيع طبية MeSH: | Galectin 1/*pharmacology , Galectin 2/*pharmacology , Galectin 4/*pharmacology , Membrane Lipids/*metabolism , Neutrophils/*metabolism , Phosphatidylserines/*metabolism , T-Lymphocytes/*metabolism, Apoptosis ; Cell Line, Tumor/cytology ; Cell Line, Tumor/drug effects ; Cells, Cultured/cytology ; Cells, Cultured/drug effects ; Dithiothreitol/pharmacology ; Galectin 1/physiology ; Galectin 2/physiology ; Galectin 4/physiology ; HL-60 Cells/cytology ; HL-60 Cells/drug effects ; HL-60 Cells/metabolism ; Humans ; Lymphocyte Activation ; N-Formylmethionine Leucyl-Phenylalanine/pharmacology ; Neutrophils/drug effects ; Neutrophils/immunology ; Organ Specificity ; Oxidation-Reduction ; Recombinant Fusion Proteins/pharmacology ; Respiratory Burst ; Surface Properties ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology |
مستخلص: | Cellular turnover is associated with exposure of surface phosphatidylserine (PS) in apoptotic cells, leading to their phagocytic recognition and removal. But recent studies indicate that surface PS exposure is not always associated with apoptosis. Here we show that several members of the human galectin family of glycan binding proteins (galectins-1, -2, and -4) induce PS exposure in a carbohydrate-dependent fashion in activated, but not resting, human neutrophils and in several leukocyte cell lines. PS exposure is not associated with apoptosis in activated neutrophils. The exposure of PS in cell lines treated with these galectins is sustained and does not affect cell viability. Unexpectedly, these galectins bind well to activated T lymphocytes, but do not induce either PS exposure or apoptosis, indicating that galectin's effects are cell specific. These results suggest novel immunoregulatory contribution of galectins in regulating leukocyte turnover independently of apoptosis. |
References: | J Immunol Methods. 1995 Jul 17;184(1):39-51. (PMID: 7622868) Annu Rev Immunol. 1999;17:593-623. (PMID: 10358769) J Clin Invest. 1999 Jul;104(1):13-9. (PMID: 10393694) J Immunol. 1999 Oct 1;163(7):3801-11. (PMID: 10490978) Biol Reprod. 1999 Oct;61(4):1162-9. (PMID: 10491658) J Pathol. 2004 Dec;204(5):511-8. (PMID: 15538736) Nat Rev Cancer. 2005 Jan;5(1):29-41. (PMID: 15630413) Stem Cells. 2005 Feb;23(2):279-87. (PMID: 15671150) J Biol Chem. 2005 Feb 18;280(7):5549-62. (PMID: 15556936) J Biol Chem. 2005 Aug 5;280(31):28623-31. (PMID: 15929990) Eur J Immunol. 2000 May;30(5):1331-9. (PMID: 10820379) Eur J Biochem. 2000 Oct;267(20):6102-9. (PMID: 11012661) Apoptosis. 2001 Dec;6(6):411-7. (PMID: 11595830) J Cell Biol. 2001 Nov 12;155(4):649-59. (PMID: 11706053) Am J Pathol. 2002 Mar;160(3):759-63. (PMID: 11891173) Glycobiology. 2002 Mar;12(3):199-208. (PMID: 11971864) Results Probl Cell Differ. 2001;33:57-83. (PMID: 11190679) J Biol Chem. 2001 Jan 12;276(2):1071-7. (PMID: 10986279) Biochem Biophys Res Commun. 2001 Mar 2;281(3):614-20. (PMID: 11237701) Cell. 2001 Feb 9;104(3):325-8. (PMID: 11239389) Cell Death Differ. 2000 Oct;7(10):911-5. (PMID: 11279536) Cell Death Differ. 2000 Oct;7(10):1002-10. (PMID: 11279547) Blood. 2001 Aug 15;98(4):1226-30. (PMID: 11493474) Biochimie. 2001 Jul;83(7):659-66. (PMID: 11522395) J Cell Biol. 2002 Jun 10;157(6):1017-28. (PMID: 12058017) J Biol Chem. 2002 Jul 26;277(30):27559-66. (PMID: 12016218) Biol Pharm Bull. 2000 Nov;23(11):1267-74. (PMID: 11085350) Immunol Rev. 2003 Jun;193:101-10. (PMID: 12752675) J Biol Chem. 2003 Oct 17;278(42):41282-93. (PMID: 12853445) Methods Enzymol. 2003;363:499-518. (PMID: 14579599) Eur Respir J Suppl. 2003 Sep;44:20s-21s. (PMID: 14582895) J Immunol. 2003 Nov 15;171(10):5100-6. (PMID: 14607908) Nature. 1995 Dec 14;378(6558):736-9. (PMID: 7501023) Radiat Res. 1996 May;145(5):542-53. (PMID: 8619019) Cell. 1997 Feb 7;88(3):347-54. (PMID: 9039261) Cell. 1997 Feb 7;88(3):355-65. (PMID: 9039262) J Exp Med. 1997 May 19;185(10):1851-8. (PMID: 9151710) J Leukoc Biol. 1997 Jun;61(6):647-53. (PMID: 9201255) Am J Respir Cell Mol Biol. 1997 Sep;17(3):272-8. (PMID: 9308912) J Mol Med (Berl). 1998 May;76(6):402-12. (PMID: 9625297) Mol Cell. 1998 Jan;1(2):161-70. (PMID: 9659913) Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9535-40. (PMID: 9689115) J Leukoc Biol. 1998 Sep;64(3):373-83. (PMID: 9738665) Cell Immunol. 1998 Aug 25;188(1):19-32. (PMID: 9743554) J Neurochem. 1998 Nov;71(5):1854-64. (PMID: 9798909) Cell Death Differ. 1998 Dec;5(12):997-1000. (PMID: 9894605) Cell. 1999 Jan 22;96(2):245-54. (PMID: 9988219) Am J Hum Genet. 1999 Apr;64(4):1002-14. (PMID: 10090885) Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13330-5. (PMID: 10557320) J Immunol. 2000 Feb 1;164(3):1322-32. (PMID: 10640746) Nature. 2000 May 4;405(6782):85-90. (PMID: 10811223) Vox Sang. 2003 Nov;85(4):307-12. (PMID: 14633257) Cancer Res. 2003 Dec 1;63(23):8302-11. (PMID: 14678989) Immunology. 2004 Jan;111(1):8-12. (PMID: 14678192) Glycobiology. 2004 Feb;14(2):157-67. (PMID: 14576172) J Biol Chem. 2004 Feb 6;279(6):4705-12. (PMID: 14617626) Glycoconj J. 2004;19(7-9):575-81. (PMID: 14758082) J Biol Chem. 2004 Apr 23;279(17):17625-33. (PMID: 14766753) Mol Biol Cell. 2004 May;15(5):2361-74. (PMID: 15004229) Mol Immunol. 2004 May;41(1):9-18. (PMID: 15140571) Science. 2004 May 21;304(5674):1123-4. (PMID: 15155940) Biochem Soc Trans. 2004 Jun;32(Pt3):461-4. (PMID: 15157160) Immunity. 2004 Jun;20(6):681-93. (PMID: 15189734) Tissue Antigens. 2004 Jul;64(1):1-12. (PMID: 15191517) Aging Cell. 2004 Aug;3(4):145-9. (PMID: 15268747) J Immunol. 2004 Sep 15;173(6):3825-37. (PMID: 15356130) J Immunol Methods. 1991 Jun 3;139(2):271-9. (PMID: 1710634) J Biol Chem. 1991 Dec 15;266(35):23648-53. (PMID: 1721052) EMBO J. 1992 May;11(5):1717-22. (PMID: 1582407) J Biol Chem. 1992 May 25;267(15):10601-6. (PMID: 1375225) Cancer Lett. 1992 Aug 31;65(3):251-7. (PMID: 1516041) J Leukoc Biol. 1993 Oct;54(4):283-8. (PMID: 8409750) J Exp Med. 1994 Mar 1;179(3):1047-52. (PMID: 8113673) J Lab Clin Med. 1994 May;123(5):741-8. (PMID: 8195679) Blood. 1994 Aug 15;84(4):1201-8. (PMID: 7519477) J Biol Chem. 1995 Mar 10;270(10):5198-206. (PMID: 7890630) |
معلومات مُعتمدة: | RR15577 United States RR NCRR NIH HHS; T32 GM008169 United States GM NIGMS NIH HHS; HL34363 United States HL NHLBI NIH HHS; R37 HL034363 United States HL NHLBI NIH HHS; P20 RR015577 United States RR NCRR NIH HHS; HL085607 United States HL NHLBI NIH HHS; P01 HL085607 United States HL NHLBI NIH HHS; R01 HL034363 United States HL NHLBI NIH HHS |
المشرفين على المادة: | 0 (Galectin 1) 0 (Galectin 2) 0 (Galectin 4) 0 (LGALS1 protein, human) 0 (Membrane Lipids) 0 (Phosphatidylserines) 0 (Recombinant Fusion Proteins) 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) T8ID5YZU6Y (Dithiothreitol) |
تواريخ الأحداث: | Date Created: 20060831 Date Completed: 20070220 Latest Revision: 20210206 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC1785076 |
DOI: | 10.1182/blood-2006-03-007153 |
PMID: | 16940423 |
قاعدة البيانات: | MEDLINE |
تدمد: | 0006-4971 |
---|---|
DOI: | 10.1182/blood-2006-03-007153 |